Efficacy and Safety Study of Lumiracoxib in Patients With Primary Hip Osteoarthritis

Inclusion Criteria: * Diagnosis of primary hip osteoarthritis * Qualifying pain intensity in the hip joint * Requiring NSAID therapy Exclusion Criteria: * Rheumatoid arthritis or other inflammatory joint disease * Disease or disorder that may interfere with pain assessment of the hip * Open knee/hip surgery within the last year * Past history of heart attack, stroke or angina (chest pain) * Liver disorder * History of severe adverse reactions of any kind under lumiracoxib or celecoxib treatment Other protocol-defined exclusion criteria may apply.